Cero Therapeutics is based in South San Francisco. It has raised $40M in total funding. Latest round: Series A.
Cero Therapeutics is based in South San Francisco. Cero Therapeutics has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2020. The round record for Cero Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Altitude Life Science Ventures, Robert Nelsen, Hongshan Capital Group (Sequoia Capital China), Richard Klausner, Milky Way Investments. 5 distinct backers are named across the disclosed rounds.
Round data for Cero Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in South San Francisco and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026